CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology.
Since its start in 1916, it has been driven by a promise to save lives using the latest technologies. Today, CSL – including our three businesses, CSL Behring, CSL Seqirus and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people.
Its unique combination of commercial strength, R&D focus and operational excellence enables it to identify, develop and deliver innovations so patients can live life to the fullest.
